![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Hologic Wins FDA Nod for Hepatitis B Assay
Hologic Wins FDA Nod for Hepatitis B Assay
![Red_Approved_Stamp.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/Red_Approved_Stamp.gif?t=1578447203&width=430)
January 25, 2018
Hologic received PMA approval for its Aptima HBV Quant Assay for measuring hepatitis B viral load on its automated Panther system.
The assay joins two other Hologic viral load assays for use on the Panther system – one for human immunodeficiency virus and one for hepatitis C virus.
They assays all use the company’s proprietary real-time transcription-mediated amplification technology and provide sample-to-result automation.
Upcoming Events
-
21Oct